Peter Mikus (PM) received his M.Sc. in Analytical Chemistry in 1995 from the Faculty of Natural Sciences Comenius University in Bratislava, Slovak Republic. He received his Ph.D. in Analytical Chemistry from the same Faculty in 2002 under the supervision of Prof. Dr. Dusan Kaniansky, an excellent analyst and expert in the field of instrumental development of capillary electomigration techniques. During his Ph.D. study, in 1997, PM joined academic and research center, namely Consiglio Nazionale delle Ricerche, Istituto di Cromatografia in Rome, Italy. Here, he made research for a period of three months under the supervision of Prof. Dr. Salvatore Fanali, an expert in the field of advanced methodology and application of chiral capillary electomigration methods. From 2002 he worked at the Faculty of Pharmacy Comenius University as a teacher and research scientist. PM received his Assoc. Prof. qualification in Pharmaceutical Chemistry from the Faculty of Pharmacy Comenius University in 2007. Currently, he is Assistant Professor, the Head of the Department of Pharmaceutical Analysis and Nuclear Pharmacy, Vice-dean for Foreign Relations and Development of the Faculty, and Departmental Erasmus Coordinator at the Faculty of Pharmacy Comenius University. Research interests of PM include development of new progressive (chiral) capillary electrophoresis separation methods for the advanced pharmaceutical and biomedical analyses of drugs, their (bio)degradation products, and biomarkers. Within this field it is mainly (i) implementation and testing of new (chiral) buffer additives in the ITP and CZE systems (i.e. advanced separation mechanisms, such as countercurrent and carrier selector systems), (ii) proposals of the 2D capillary electrophoresis methods for the ultratrace analytes present in the multicomponent matrices (i.e. advanced sample preparation, such as on-line sample concentration and clean-up), and (iii) study of analytical possibilities of the hyphenated electrophoretic and detection techniques (i.e. advanced detection stage, such as spectral DAD, LIF, MS: QQQ, Q-TOF for the decreasing of the detection limits and/or structural identification of the known as well as unknown analytes). Within his current research, supported by and carried out in the Excellence Center of Pharmacy at the Faculty of Pharmacy Comenius University, are besides the advanced electrophoretic methods also advanced chromatographic ones (HPLC/2D HPLC-Q-TOF/QQQ). These are developed for the current pharmaceutical and biomedical research program of the Faculty of Pharmacy Comenius University and cooperating institutions.